Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 8, 2007 - Issue 2
Submit an article Journal homepage
477
Views
22
CrossRef citations to date
0
Altmetric
ORIGINAL INVESTIGATION

Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: A 4-week open-label parallel-group study

Cornelius Schüle Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, GermanyCorrespondence[email protected]
, MD,
Thomas C. Baghai Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany
,
Daniela Eser Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany
,
Susanne Hecht Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany
,
Igor Hermisson Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany
,
Christoph Born Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany
,
Sibylle Häfner Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany
,
Caroline Nothdurfter Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany
&
Rainer Rupprecht Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany
 show all
Pages 112-122 | Received 15 Sep 2006, Published online: 12 Jul 2009

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Shuxin Luan, Hongquan Wan, Lei Zhang & Hua Zhao. (2018) Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials. Neuropsychiatric Disease and Treatment 14, pages 467-477.
Read now
Alan L Pehrson & Connie Sanchez. (2015) Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants. Drug Design, Development and Therapy 9, pages 603-624.
Read now
Changsu Han, Sheng-Min Wang, Masaki Kato, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masand & Chi-Un Pae. (2013) Second-generation antipsychotics in the treatment of major depressive disorder: current evidence. Expert Review of Neurotherapeutics 13:7, pages 851-870.
Read now
Sidney H Kennedy & Sakina J Rizvi. (2009) Emerging drugs for major depressive disorder. Expert Opinion on Emerging Drugs 14:3, pages 439-453.
Read now
Julien Mendlewicz. (2009) Sleep disturbances: Core symptoms of major depressive disorder rather than associated or comorbid disorders. The World Journal of Biological Psychiatry 10:4, pages 269-275.
Read now
J Craig Nelson, Andrei Pikalov & Robert M Berman. (2008) Augmentation treatment in major depressive disorder: focus on aripiprazole. Neuropsychiatric Disease and Treatment 4:5, pages 937-948.
Read now
Arif Khan. (2008) Current evidence for aripiprazole as augmentation therapy in major depressive disorder. Expert Review of Neurotherapeutics 8:10, pages 1435-1447.
Read now

Articles from other publishers (15)

Akanksha Sonal & Shrikant Srivastava. (2022) Aripiprazole as First-Line Therapy for Late-Life Depression. Journal of Clinical Psychopharmacology 42:3, pages 280-283.
Crossref
Mellar P. Davis. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1281 1309 .
Mellar P. Davis. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 29 .
Yojiro Umezaki, Akihito Uezato, Akira Toriihara, Toru Nishikawa & Akira Toyofuku. (2017) Two Cases of Oral Somatic Delusions Ameliorated With Brain Perfusion Asymmetry: A Case Report. Clinical Neuropharmacology 40:2, pages 97-99.
Crossref
Max Schmauß & Thomas Messer. 2016. Polypharmazie in der Behandlung psychischer Erkrankungen. Polypharmazie in der Behandlung psychischer Erkrankungen 1 39 .
A. L. D’yakonov & I. V. Lobanova. (2014) Comparative Studies of the Efficacy of Combinations of SSRI Antidepressants and Antipsychotics in the Treatment of Recurrent Depressive Disorder. Neuroscience and Behavioral Physiology 44:2, pages 195-199.
Crossref
Chi-Un PaeHo-Jun SeoBoung Chul LeeJeong-Ho SeokHong Jin JeonJong-Woo PaikKyung-Phil KwakByung-Joo HamChangsu HanSoo-Jung Lee. (2014) A Meta-Analysis Comparing Open-Label versus Placebo-Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and Promises. Psychiatry Investigation 11:4, pages 371.
Crossref
Chi-Un Pae, Andy Forbes & Ashwin A. Patkar. (2011) Aripiprazole as Adjunctive Therapy for Patients with Major Depressive Disorder. CNS Drugs 25:2, pages 109-127.
Crossref
Arnim Quante, Sara Zeugmann, Alexander Luborzewski, Nicole Schommer, Jens Langosch, Christoph Born, Ion Anghelescu & Juergen Wolf. (2010) Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo‐controlled pilot study. Human Psychopharmacology: Clinical and Experimental 25:2, pages 126-132.
Crossref
Richard C. Shelton, Olawale Osuntokun, Alexandra N. Heinloth & Sara A. Corya. (2010) Therapeutic Options for Treatment-Resistant Depression. CNS Drugs 24:2, pages 131-161.
Crossref
I. Pacchiarotti, L. Mazzarini, F. Colom, J. Sanchez-Moreno, P. Girardi, G. D. Kotzalidis & E. Vieta. (2009) Treatment-resistant bipolar depression: towards a new definition. Acta Psychiatrica Scandinavica 120:6, pages 429-440.
Crossref
Lakshmi N Yatham, Sidney H Kennedy, Ayal Schaffer, Sagar V Parikh, Serge Beaulieu, Claire O'Donovan, Glenda MacQueen, Roger S McIntyre, Verinder Sharma, Arun Ravindran, L Trevor Young, Allan H Young, Martin Alda, Roumen Milev, Eduard Vieta, Joseph R Calabrese, Michael Berk, Kyooseob Ha & Flávio Kapczinski. (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders 11:3, pages 225-255.
Crossref
Thomas Messer & Max SchmaußMax Schmauss & Thomas Messer. 2009. Polypharmazie in der Behandlung psychischer Erkrankungen. Polypharmazie in der Behandlung psychischer Erkrankungen 1 51 .
Robin Hieber, Timothy Dellenbaugh & Leigh Anne Nelson. (2008) Role of Mirtazapine in the Treatment of Antipsychotic-Induced Akathisia. Annals of Pharmacotherapy 42:6, pages 841-846.
Crossref
Mehmet A Ersoy, Aysin M Noyan & Hayriye Elbi. (2008) An Open-Label Long-Term Naturalistic Study of Mirtazapine Treatment for Depression in Cancer Patients. Clinical Drug Investigation 28:2, pages 113-120.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.